Cargando…
Different dosage regimens of Eptinezumab for the treatment of migraine: a meta-analysis from randomized controlled trials
BACKGROUND: Migraine is one of the most common neurological diseases around the world and calcitonin gene-related peptide (CGRP) plays an important role in its pathophysiology. Therefore, in the present study, we evaluated the efficacy of monoclonal antibodies blocking the CGRP ligand or receptor in...
Autores principales: | Yan, Zeya, Xue, Tao, Chen, Shujun, Wu, Xin, Yang, Xingyu, Liu, Guangjie, Gao, Shan, Chen, Zhouqing, Wang, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937260/ https://www.ncbi.nlm.nih.gov/pubmed/33676408 http://dx.doi.org/10.1186/s10194-021-01220-y |
Ejemplares similares
-
Eptinezumab for migraine
Publicado: (2022) -
Is Fluoxetine Good for Subacute Stroke? A Meta-Analysis Evidenced From Randomized Controlled Trials
por: Liu, Guangjie, et al.
Publicado: (2021) -
A Review of Eptinezumab Use in Migraine
por: Datta, Abhigyan, et al.
Publicado: (2021) -
The Function of Tranexamic Acid to Prevent Hematoma Expansion After Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis From Randomized Controlled Trials
por: Yan, Zeya, et al.
Publicado: (2021) -
Eptinezumab for migraine prevention in patients 50 years or older
por: Martin, Vincent, et al.
Publicado: (2022)